Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Colorectal > Rectal Cancer > Flashcards

Rectal Cancer Flashcards

1
Q

What is TME?

A

Procedure performed during low anterior resection for middle/low rectal tumor, in which mesorectum is removed along with rectum to the level of elevators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Evidence for TME

A 
reduce risk of local recurrence 
improves survival (5 year and overall disease free survival)

Landmark: Heald Lancet 1986)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Quirke grading of TME specimen

1) Gradings
2) Criteria
3) Evidence

A

1) 3-Good, 2-Moderate, 1-Poor
2)
- intactness of mesorectum
- defects in specimen
- bulk
- coning
- irregularity of CRM
3) Quirke 2009 Lancet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clearance margins for rectal tumors

A

Distal 2cm mucosal margin
Proximal 5cm
CRM >2mm
Excision of CRM 5cm beyond distal margin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Defunctioning stoma, pros and cons of

1) loop ileostomy
2) transverse colostomy

A

1)
+less risk of prolapse
-high output stoma
2)
- prolapse
-risk of compromised marginal artery on closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Low rectal cancer

A

MRI confirms lower edge of tumor below origins of the levator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TAMIS

A

use of single-site port transanally in conjunction with ordinary laparoscopic instruments/camera, standard lap CO2 insufflator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the mesorectum?

A

perirectal tissue composed of fat, lymphatics and blood vessels contained within the endopelvic visceral fascia, extending the whole length of rectum down to pelvic diaphragm and attaches the rectum to pelvic sidewall and sacrum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Indications for local excision of early rectal cancer

A

T1N0 or less
well - mod diff tumor
size < 4cm
clear margin feasible
tumor involving < 30% rectal wall circumference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Evidence for MRI for assessment of CRM involvement

A

MERCURY study (BMJ 2006)

MRI 92% specificity for predictions of clear CRM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Preoperative CRT for rectal cancer

1) Advantages
2) Disadvantages

A

1)
-sterilization fo mesorectal lymphatic channels
-downstaging
-exclusion fo small bowel from radiation field
-superior function of non-irradiated neo-rectum
2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is SCPRT? What is the regimen?

A

Short course preoperative radiotherapy

  • 25 Gy total dose at 5Gy/fraction during 1 week
  • Followed by immediate surgery <10 days after first radiation fraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the regimen of long course chemoradiotherapy?

A
  • 1.8-2Gy over 25-28 days with concurrent chemo as radiosensitizer
  • Radical surgery delayed for 6-8 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is pCR? What percentage of patients achieve pCR after neoadjuvant chemo?

A

Pathological complete response

25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T3a

A

<1mm invasion beyond muscularis propria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T3b

A

1-5mm invasion beyond muscularis propriae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

T3c

A

6-15mm invasion beyond muscularis propria

18
Q

T3d

A

>15mm invasion beyond muscularis propriae

19
Q

What is cCR?

A

Clinical complete response

  • absence of any palpable tumour or
  • no irregularity at DRE,
  • no visible lesion at proctoscopy except a flat scar/ telangiectasia / whitening of the mucosa.
20
Q

What is watch and wait approach?

A

Non operative strategy of intensive surveillance after achieve pCR

21
Q

What is the optimal time after CRT for surgery?

A

6-12 weeks

Shorter: inadequate tumour shrinkage, side effects from CRT

Longer: fibrosis leading to higher surgical morbidity, disease progression

22
Q

Theoretical advantages of neoadjuvant chemoradiotherapy

A
  • downstaging to allow resectiability + sphincter preservation
  • sterilization of mesorectal lymphatics
  • radiosensitizer
  • better function of the non-irradiated neorectum
23
Q

Theoretical disadvantages of preop CRT

A
  • Pathological understanding leading to subsequent under-treatment
  • tumor progression between period of neoadjuvant tx and surgery
  • perioperative complications
24
Q

Choice of chemotherapy with RT

A

Fluoropyrimidine

  • 5-FU
  • Capecitabine
25
Q

Choice of chemotherapy with RT

A

Fluoropyrimidine

  • 5-FU
    • FOLFOX: infusional 5FU
    • XELOX: infusional + oral
    • FLOX: bolus 5FU
  • Capecitabine
26
Q

Evidence for SCPRT

A
  • Swedish Rectal Cancer Trial 1997 NEJM
  • Dutch TME Trial 2001 NEJM
  • MRC (CR07) -NCIC (CTGC016)
27
Q

Evidence for long course CRT

A
  • German Rectal Cancer Study Group 2004 NEJM
  • NASBP R-03
  • Korean trial
28
Q

What is TNT?

A

Total neoadjuvant therapy

oxaliplatin-based chemotherapy combined with long-course CRT or short-course RT

for locally advanced rectal cancer, with high risk for margin positive resection

29
Q

Complications of acute toxicity in RT

A
  • GI disturbance
  • Radiation enteritis
  • Lethargy/weakness
  • Leukopenia
  • Skin reaction
30
Q

Late complications of RT

A
  • Bowel stricture
  • Chronic diarrhea
  • Thromboembolism
  • AVN of hip
  • Secondary cancer
  • Pelvic floor dysfunction
  • Infertility/ Erectile Dysfunction / Dyspareunia
31
Q

Purposed of colonic stenting

A

Bridge to surgery

Palliative intent

32
Q

Advantages of stenting for bridge to surgery?

A
  • Convert emergency to elective, reduce surgical mortality
  • Allow nutrition boost
  • Time for full bowel evaluation
  • lower stoma rate
33
Q

Risks of stenting

A
  • Perforation 5%
  • Bleeding 5%
  • Stent migration 5-10%
  • Stent occlusion
  • Technical success 70-90%
  • Mortality 0-1 %
34
Q

Time to surgery after stenting

A

5-10 days (ESGE guidelines)

Some centres up to 2-4 weeks

35
Q

Concerns with stenting

A

Oncological risk: Several RCT/prospective studies show higher recurrence rate

No different in overall survival

36
Q

Would you recommend stenting as bridge to elective surgery?

A

In general as evidence points to worsening disease free survival, stenting as bridge to elective surgery not recommended compared to emergency surgery EXCEPT in selected cases of left sided obstructing tumor where patient high risk of postoperative mortality (ASA III, Age > 70)

37
Q

Contraindications to stenting

A

Peritonitis

Suspected perforation

Low rectal tumors

38
Q

Median duration of stent patency

A

106 days (68-288)

39
Q

Surveillance after resection of colorectal cancer

A
  • FU 4-6wks after surgery
  • Minimum 2 sets of CT TAP in first 3 years
  • CEA at least 6mthly in first 3 yrs
  • CLN 1 year after OT then 5 years then dependent on CLN findings
  • Reinvestigate prn if clinical/ radiological/ biochemical suspicious of recurrence
40
Q

What is the management of local recurrent of rectal cancer?

A
  • MDT
  • Curative surgery vs +/- neoadjuvant if no hx of RT
  • Aim R0 resection
  • Inoperable => palliative CRT

Colorectal (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions